Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Oxybutynin chloride;Oxybutynin HCl;Oxybutynin hydrochloride | C22H32ClNO3 | 1508-65-2 | Details |
Bixin | C25H30O4 | 6983-79-5 | Details |
Atuveciclib Racemate;BAY-1143572 Racemate | C18H18FN5O2S | 1414943-88-6 | Details |
Bay 41-4109 | C18H13ClF3N3O2 | 298708-81-3 | Details |
5-HT2A antagonist 1 | C26H28N4O2 | 204643-75-4 | Details |
BAY 73-6691 racemate | C15H12ClF3N4O | 794568-90-4 | Details |
BCL6-IN-3 | C24H31ClF2N6O2 | 2253878-44-1 | Details |
Galidesivir hydrochloride;Immucillin-A hydrochloride;BCX 4430 hydrochloride | C11H16ClN5O3 | 222631-44-9 | Details |
Befiradol;F13640;NLX-112 | C20H22ClF2N3O | 208110-64-9 | Details |
Beclabuvir;BMS-791325 | C36H45N5O5S | 958002-33-0 | Details |
BCI hydrochloride;(E)-BCI hydrochloride | C22H24ClNO | 95130-23-7 | Details |
BCR-ABL-IN-2 | C24H25Cl2N5O3 | 897369-18-5 | Details |
H3 receptor-MO-1 | C20H27N3O2 | 1240914-03-7 | Details |
CB1 antagonist 1 | C26H22Cl2N4 | 890037-68-0 | Details |
BCR-ABL-IN-1 | C23H21F4N5O | 188260-50-6 | Details |
bio-THZ1 | C52H65ClN12O8S | 1604811-14-4 | Details |
ODM-207;ODM207;BET-IN-4 | C22H21N3O3 | 1801503-93-4 | Details |
BAY-784 | C29H26ClF4N3O5S2 | 1631164-24-3 | Details |
Estradiol;17β-Estradiol;β-Estradiol;17β-Oestradiol;E2 | C18H24O2 | 50-28-2 | Details |
Bitopertin (R enantiomer);RG1678 (R enantiomer);RO4917838 (R enantiomer);Bitopertin R enantiomer | C21H20F7N3O4S | 845614-12-2 | Details |
Bicyclomycin benzoate;FR2054 | C19H22N2O8 | 37134-40-0 | Details |
I-BET282;BET-IN-1 | C25H30N4O4 | 1422554-34-4 | Details |
FR252384 | C18H17N3 | 447405-11-0 | Details |
BAY-1816032 | C27H24F2N6O4 | 1891087-61-8 | Details |
Mebeverine hydrochloride;Duspatal Hydrochloride;Colofac Hydrochloride;Duspatalin Hydrochloride | C25H35NO5.ClH | 2753-45-9 | Details |
Proglumide;Xylamide;Binoside | C18H26N2O4 | 6620-60-6 | Details |
BAY 60-2770 | C35H33F4NO5 | 1027642-43-8 | Details |
Oxybutynin;Oxytrol;Oxibutyninum;Ditropan | C22H31NO3 | 5633-20-5 | Details |
BAY 73-6691;(R)-BAY 73-6691 | C15H12ClF3N4O | 794568-92-6 | Details |
Bithionol sulfoxide | C12H6Cl4O3S | 844-26-8 | Details |
Asthma relating compound 1 | C17H19N3O3S2 | 120165-51-7 | Details |
Bisindolylmaleimide VIII acetate;Bis VIII acetate;Ro 31-7549 acetate | C24H22N4O2 | 138516-31-1 | Details |
Retinoic acid;ATRA;all-trans-Retinoic acid;Tretinoin;Vitamin A acid | C20H28O2 | 302-79-4 | Details |
BIBO3304 TFA | C31H36F3N7O5 | 191868-14-1 | Details |
Bay 41-4109 (less active enantiomer) | C18H13ClF3N3O2 | 476617-51-3 | Details |
YM158 free base;YM-57158 | C32H33ClN6O5S2 | 179102-65-9 | Details |
PPARα-MO-1 | C27H37NO5 | 810677-36-2 | Details |
BAY-7598 | C28H31N3O6 | 1816257-74-5 | Details |
β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
Beperidium iodide;SX 810 | C23H34N3O3.I | 86434-57-3 | Details |
Benzothiohydrazide | C7H8N2S | 20605-40-7 | Details |
BD-AcAc 2;Ketone Ester | C8H16O4 | 1208313-97-6 | Details |
BIBP3226 TFA | C29H32F3N5O5 | 1068148-47-9 | Details |
Antibacterial compound 1 | C14H16FN3O4 | 232951-56-3 | Details |
BI-2852 | C31H28N6O2 | 2375482-51-0 | Details |
β3-AR agonist 1 | C22H28N4O4S | 1283125-73-4 | Details |
BET-IN-2 | C23H29N3O | 2104688-91-5 | Details |
Tolbutamide;HLS 831 | C12H18N2O3S | 64-77-7 | Details |
Lisaftoclax;Bcl-2/Bcl-xl inhibitor 1 | C45H48ClN7O8S | 2180923-05-9 | Details |
Bexarotene D4;LGD1069 D4 | C24H24D4O2 | 2182068-00-2 | Details |
BioE-1115 | C19H18FN3O2 | 1268863-35-9 | Details |
BAY-Y 3118 | C20H21ClFN3O3 | 151213-16-0 | Details |
Anti-Heart Failure Agent 1 | C11H11FN2O3S | 142648-47-3 | Details |
BI 653048 | C23H25F4N3O4S | 1198784-72-3 | Details |
BF 227 | C16H16FN3O2S | 845647-80-5 | Details |
Benralizumab;MEDI-563;BIW-8405 | 1044511-01-4 | Details |
BAY-985 | C27H30F3N9O | 2409479-29-2 | Details |
Prazosin hydrochloride;Peripress;Minipress;Vasoflex;cp-12299-1;Prazosin HCl | C19H22ClN5O4 | 19237-84-4 | Details |
Bavisant dihydrochloride hydrate;JNJ31001074AAC | C19H30ClN3O3 | 1103522-80-0 | Details |
BGB-102;JNJ-26483327 | C22H25BrN4O2 | 807640-87-5 | Details |
BCI;(E)-BCI | C22H23NO | 1245792-51-1 | Details |
BB-Cl-Amidine | C26H26ClN5O | 1802637-39-3 | Details |
ACAT-IN-1 cis isomer | C29H25NO2 | 145961-79-1 | Details |
PPAR agonist 1 | C20H25NO6S | 539813-69-9 | Details |
BAY885 | C25H28F3N7O2 | 2307249-33-6 | Details |
β-Cryptoxanthin;(3R)-β-Cryptoxanthin | C40H56O | 472-70-8 | Details |
BI 653048 phosphate | C23H28F4N3O8PS | 1198784-97-2 | Details |
BI-1408 | C22H23FN6 | 2231075-94-6 | Details |
Bencianol;ZY15051 | C28H22O6 | 85443-48-7 | Details |
Beclomethasone 17-propionate;17-BMP;Beclomethasone-17-monopropionate | C25H33ClO6 | 5534-18-9 | Details |
Bay 65-1942 free base | C22H25N3O4 | 600734-02-9 | Details |
BIO-32546 | C28H31F6NO3 | 1548743-66-3 | Details |
BIX-01338 hydrate;BIX 01338 hydrate;BIX01338 hydrate | C32H26F3N3O7 | 1228184-65-3 | Details |
Prenyl-IN-1 | C28H24ClN5O2 | 360561-53-1 | Details |
Ifosfamide;NSC109724;Isophosphamide | C7H15Cl2N2O2P | 3778-73-2 | Details |
BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
BCL2-IN-1 | C47H54ClN7O7S | 1257044-75-9 | Details |
Galidesivir;BCX4430;Immucillin-A | C11H15N5O3 | 249503-25-1 | Details |
Bay 65-1942 (R form);Bay 65-1942 R form | C22H25N3O4 | 758683-21-5 | Details |
Bisindolylmaleimide X hydrochloride;Ro31-8425 hydrochloride;BIM-X hydrochloride | C26H25ClN4O2 | 145317-11-9 | Details |
Biotin-VAD-FMK | C30H49FN6O8S | 1135688-15-1 | Details |
Xanthine oxidase-IN-1;4-(3-Cyano-5,6-difluoroindol-1-yl)-2-hydroxybenzoic acid | C16H8F2N2O3 | 1071970-13-2 | Details |
Anti-hypertensive sulfonanilide 1 | C35H37ClN5O6S2 | 129280-22-4 | Details |
BAY-678 | C20H15F3N4O2 | 675103-36-3 | Details |
BF-168 | C18H17FN2O2 | 634911-47-0 | Details |
BAY-677 | C20H15F3N4O2 | 2117404-84-7 | Details |
Bax inhibitor peptide V5;BIP-V5;BAX Inhibiting Peptide V5 | C27H50N6O6S | 579492-81-2 | Details |
PROTAC Bcl2 degrader-1 | C45H45BrN6O10S | 2378801-85-3 | Details |
BI-9321 trihydrochloride | C22H22ClFN4 | 2387510-87-2 | Details |
Bifeprunox | C24H23N3O2 | 350992-10-8 | Details |
Bavisant dihydrochloride | C19H28ClN3O2 | 929622-09-3 | Details |
BET-BAY 002 | C22H18ClN5O | 1588521-78-1 | Details |
Implitapide Racemate | C35H37N3O2 | 177277-99-5 | Details |
GPR40 Agonist 2 | C24H30O3 | 1147729-48-3 | Details |
(S)-ML753286 | C20H25N3O3 | 1699720-85-8 | Details |
BI-749327 | C23H21F3N4O2 | 2361241-23-6 | Details |
Betrixaban-d6;Betrixaban D6 | C23H22ClN5O3 | 2098655-51-5 | Details |
BAY-1797 | C20H17ClN2O4S | 2055602-83-8 | Details |
BI-9321 | C22H21FN4 | 2387510-86-1 | Details |
Benzcyclane;Benzcyclan;Bencyclane | C19H31NO | 2179-37-5 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 |